HomeCompareBAX vs ADI

BAX vs ADI: Dividend Comparison 2026

BAX yields 2.28% · ADI yields 1.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADI wins by $125.1K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
ADI
ADI
● Live price
1.34%
Share price
$303.10
Annual div
$4.07
5Y div CAGR
61.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$145.7K
Annual income
$66,714.92
Full ADI calculator →

Portfolio growth — BAX vs ADI

📍 ADI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXADI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + ADI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
ADI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
ADI
Annual income on $10K today (after 15% tax)
$114.14/yr
After 10yr DRIP, annual income (after tax)
$56,707.68/yr
At 15% tax rate, ADI beats the other by $56,698.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + ADI for your $10,000?

BAX: 50%ADI: 50%
100% ADI50/50100% BAX
Portfolio after 10yr
$83.2K
Annual income
$33,362.59/yr
Blended yield
40.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADI right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
ADI
Analyst Ratings
43
Buy
11
Hold
Consensus: Buy
Price Target
$374.42
+23.5% upside vs current
Range: $270.00 — $430.00
Altman Z
7.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
ADI buys
0
No recent congressional trades found for BAX or ADI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXADI
Forward yield2.28%1.34%
Annual dividend / share$0.36$4.07
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%61.9%
Portfolio after 10y$20.6K$145.7K
Annual income after 10y$10.26$66,714.92
Total dividends collected$602.00$118.1K
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldBuy
Analyst price target$19.75$374.42

Year-by-year: BAX vs ADI ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrADI PortfolioADI Income/yrGap
1← crossover$10,866$166.33$10,917$217.40$51.00ADI
2$11,750$123.31$12,041$359.12$291.00ADI
3$12,664$90.97$13,483$599.29$819.00ADI
4$13,617$66.89$15,442$1,015.38$1.8KADI
5$14,619$49.07$18,283$1,759.59$3.7KADI
6$15,679$35.94$22,715$3,152.16$7.0KADI
7$16,802$26.30$30,230$5,925.67$13.4KADI
8$17,998$19.23$44,279$11,932.68$26.3KADI
9$19,272$14.05$73,824$26,445.87$54.6KADI
10$20,631$10.26$145,707$66,714.92$125.1KADI

BAX vs ADI: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

ADITechnology

Analog Devices, Inc. designs, manufactures, tests, and markets integrated circuits (ICs), software, and subsystems that leverage analog, mixed-signal, and digital signal processing technologies. The company provides data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; power management and reference products for power conversion, driver monitoring, sequencing, and energy management applications in the automotive, communications, industrial, and high-end consumer markets; and power ICs include performance, integration, and software design simulation tools for accurate power supply designs. It also offers high-performance amplifiers to condition analog signals; and radio frequency and microwave ICs to support cellular infrastructure; and microelectromechanical systems technology solutions, including accelerometers used to sense acceleration, gyroscopes for sense rotation, inertial measurement units to sense multiple degrees of freedom, and broadband switches for radio and instrument systems, as well as isolators. In addition, the company offers digital signal processing and system products for high-speed numeric calculations. It serves clients in the industrial, automotive, consumer, instrumentation, aerospace, and communications markets through a direct sales force, third-party distributors, and independent sales representatives in the United States, the rest of North and South America, Europe, Japan, China, and rest of Asia, as well as through its Website. Analog Devices, Inc. was incorporated in 1965 and is headquartered in Wilmington, Massachusetts.

Full ADI Calculator →
📬

Get this BAX vs ADI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.